SMP-3124LP in Adults With Advanced Solid Tumors
Clinical trial NCT06526819 · RECRUITING
Trial details
- NCT number
- NCT06526819
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-14
- Primary completion
- 2028-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.